[{"question": "A 65-year-old female is diagnosed with invasive ductal carcinoma of the breast. After a lumpectomy with a negative axillary lymph node dissection and subsequent radiation therapy, the patient is started on adjuvant chemotherapy with anastrozole. Which of the following is an expected side effect of this medication?", "correct_answer": "Increased risk for osteoporosis", "correct_idx": 2, "options": ["A)Increased risk for endometrial carcinoma", "B)Decreased LDL and increased HDL levels", "C)Increased risk for osteoporosis", "D)Excessive weight loss"], "prompt": "A 65-year-old female is diagnosed with invasive ductal carcinoma of the breast. After a lumpectomy with a negative axillary lymph node dissection and subsequent radiation therapy, the patient is started on adjuvant chemotherapy with anastrozole. Which of the following is an expected side effect of this medication?A)Increased risk for endometrial carcinoma\nB)Decreased LDL and increased HDL levels\nC)Increased risk for osteoporosis\nD)Excessive weight loss", "subject_name": null, "output0": "Anastrozole, a selective estrogen receptor modulator (SERM), is used to treat hormone-sensitive breast cancer. One of the potential side effects of this medication is an increased risk for endometrial carcinoma, as it can cause an overgrowth of the endometrium.\n\n", "output1": "Anastrozole is an aromatase inhibitor, which works by blocking the enzyme aromatase that converts androgens to estrogens. This can lead to decreased levels of low-density lipoprotein (LDL) cholesterol and increased levels of high-density lipoprotein (HDL) cholesterol.\n\n", "output2": "Anastrozole, a medication used to treat hormone-sensitive breast cancer, can increase the risk of osteoporosis, particularly in postmenopausal women. This is because it blocks the production of estrogen, which is important for bone health.\n\n", "output3": "Anastrozole, a selective estrogen receptor modulator (SERM), is commonly used in the adjuvant treatment of hormone receptor-positive breast cancer. One of the most common side effects of this medication is weight loss, which can be excessive in some cases.\n\n"}, {"question": "Statements about Medvedev plexus (Meissner's plexus), and what's right?", "correct_answer": "Regulating the secretion of glands and mucosa peristalsis", "correct_idx": 0, "options": ["A)Regulating the secretion of glands and mucosa peristalsis", "B)Distributed in the muscle layer of the digestive tract", "C)Similarly sympathetic stimulate sphincter function", "D)In serosa common"], "prompt": "Statements about Medvedev plexus (Meissner's plexus), and what's right?A)Regulating the secretion of glands and mucosa peristalsis\nB)Distributed in the muscle layer of the digestive tract\nC)Similarly sympathetic stimulate sphincter function\nD)In serosa common", "subject_name": null, "output0": "The Medvedev plexus, also known as Meissner's plexus, is a network of nerves that regulates the secretion of glands and mucosa peristalsis in the digestive tract. It is not distributed in the muscle layer of the digestive tract, as the muscles are not innervated by the Medvedev plexus. Similarly, the Medvedev plexus does not stimulate sphincter function, as the sphincter muscles are controlled by the sympathetic nervous system.\n\n", "output1": "The correct answer is that the Meissner's plexus is distributed in the muscle layer of the digestive tract. This plexus is responsible for regulating the secretion of glands and mucosa peristalsis, but it is not found in the serosa or the muscle layer.\n\n", "output2": "The Medvedev plexus, also known as Meissner's plexus, is a network of nerve fibers that regulates the secretion of glands and mucosa peristalsis. It is located in the muscle layer of the digestive tract and is responsible for sympathetically stimulating sphincter function.\n\n", "output3": "The correct answer is D)In serosa common. Medvedev plexus (Meissner's plexus) is a network of nerve fibers that is found in the serosa, or the connective tissue layer, of the digestive tract. It is responsible for regulating the secretion of glands and mucosa peristalsis, and it is distributed in the muscle layer of the digestive tract. It also has a sympathetic stimulation of sphincter function.\n\n"}, {"question": "Water content in enamel by volume", "correct_answer": "6-7%", "correct_idx": 1, "options": ["A)2-3%", "B)6-7%", "C)20-25%", "D)10-12%"], "prompt": "Water content in enamel by volumeA)2-3%\nB)6-7%\nC)20-25%\nD)10-12%", "subject_name": "Dental", "output0": "The water content in enamel by volume is typically around 2-3%. This is because enamel is a hard, mineralized tissue that is composed of a combination of hydroxyapatite and water. The water content helps to keep the enamel soft and pliable, allowing it to be easily shaped and molded.\n\n", "output1": "The correct answer is B)6-7% because the water content in enamel by volume is approximately 6-7%. This is a critical range for enamel to maintain its structure and function.\n\n", "output2": "The correct answer is C)20-25% because water is an essential component of enamel, and it plays a crucial role in maintaining the integrity and health of the tooth structure. Enamel contains about 20-25% water by volume.\n\n", "output3": "The water content in enamel is typically around 10-12% by volume. This is the range that is considered normal and healthy for the enamel.\n\n"}, {"question": "Which anti-cholinergic drug doesn't cross the blood brain barrier and placenta?", "correct_answer": "Glycopyrrolate bromide", "correct_idx": 0, "options": ["A)Glycopyrrolate bromide", "B)Hyoscine bromide", "C)Hyoscine butylbromide", "D)Atropine"], "prompt": "Which anti-cholinergic drug doesn't cross the blood brain barrier and placenta?A)Glycopyrrolate bromide\nB)Hyoscine bromide\nC)Hyoscine butylbromide\nD)Atropine", "subject_name": "Pharmacology", "output0": "Glycopyrrolate bromide is an anti-cholinergic drug that does not cross the blood-brain barrier or the placenta, which means it does not affect the central nervous system or the developing fetus. This makes it a safer option for use in pregnant women and children.\n\n", "output1": "Hyoscine bromide is an anti-cholinergic drug that does not cross the blood-brain barrier or the placenta. This means that it does not affect the central nervous system or the developing fetus.\n\n", "output2": "Hyoscine butylbromide is a quaternary ammonium compound that does not cross the blood-brain barrier or the placenta, making it a safe choice for use in pregnant women and children. The other options, glycopyrrolate bromide, hyoscine bromide, and atropine, are all anti-cholinergic drugs that can cross the blood-brain barrier and the placenta, and are not recommended for use in pregnant women or children.\n\n", "output3": "Atropine is a highly lipophilic molecule and therefore does not cross the blood-brain barrier or the placenta, making it a safe choice for use in pregnant women and children. Glycopyrrolate bromide, hyoscine bromide, and hyoscine butylbromide are all anti-cholinergic drugs that can cross the blood-brain barrier and the placenta, and therefore may be less suitable for use in certain populations.\n\n"}, {"question": "Binder present in phosphate bonded investment material is:", "correct_answer": "Both 1&2", "correct_idx": 3, "options": ["A)Magnesium oxide", "B)Monoammonium phosphate", "C)Magnesium phosphate", "D)Both 1&2"], "prompt": "Binder present in phosphate bonded investment material is:A)Magnesium oxide\nB)Monoammonium phosphate\nC)Magnesium phosphate\nD)Both 1&2", "subject_name": "Dental", "output0": "The binder present in phosphate bonded investment material is magnesium oxide. This is because magnesium oxide is a strong binder and helps to improve the mechanical properties of the investment material.\n\n", "output1": "Monoammonium phosphate is a common binder present in phosphate-bonded investment materials. It helps to improve the strength and durability of the material by forming a strong bond between the particles.\n\n", "output2": "The binder present in phosphate bonded investment material is magnesium phosphate. This binder is formed when magnesium oxide and phosphate ions react together during the investment process.\n\n", "output3": "The binder present in phosphate bonded investment material is both magnesium oxide and monoammonium phosphate.\n\n"}, {"question": "A 54-year-old woman presents to her primary care physician complaining of a lump in her right breast. She first noticed it 1 month ago. Now she is worried that it may have grown. She claims that the lump is not painful or itchy, and she denies any abnormal nipple bleeding or discharge. She has a family history of breast cancer, including both her mother and older sister. Physical examination reveals a firm, immobile lump in the upper right breast. A mammogram is performed, which identifies an irregular mass with a fibrotically stranded border. A biopsy is performed that is positive for invasive ductal carcinoma. The patient is started on radiation induction therapy and scheduled for a modified radical mastectomy. Following tumor gene testing, the patient is found to be positive or the HER-2/neu oncogene. Which of the following should be started post-mastectomy to improve the patient\u2019s prognosis?", "correct_answer": "Trastuzumab", "correct_idx": 3, "options": ["A)Anastrozole", "B)Corticosteroids", "C)Leuprolide", "D)Trastuzumab"], "prompt": "A 54-year-old woman presents to her primary care physician complaining of a lump in her right breast. She first noticed it 1 month ago. Now she is worried that it may have grown. She claims that the lump is not painful or itchy, and she denies any abnormal nipple bleeding or discharge. She has a family history of breast cancer, including both her mother and older sister. Physical examination reveals a firm, immobile lump in the upper right breast. A mammogram is performed, which identifies an irregular mass with a fibrotically stranded border. A biopsy is performed that is positive for invasive ductal carcinoma. The patient is started on radiation induction therapy and scheduled for a modified radical mastectomy. Following tumor gene testing, the patient is found to be positive or the HER-2/neu oncogene. Which of the following should be started post-mastectomy to improve the patient\u2019s prognosis?A)Anastrozole\nB)Corticosteroids\nC)Leuprolide\nD)Trastuzumab", "subject_name": null, "output0": "The patient has been diagnosed with invasive ductal carcinoma and is positive for the HER-2/neu oncogene. Anastrozole is a selective estrogen receptor modulator (SERM) that has been shown to improve outcomes in patients with hormone receptor-positive breast cancer, which includes HER-2/neu-positive tumors. Additionally, anastrozole has been shown to be effective in reducing the risk of recurrence in postmenopausal women with early-stage breast cancer.\n\n", "output1": "Corticosteroids are recommended to improve the patient\u2019s prognosis post-mastectomy because they have been shown to reduce the risk of recurrence and improve overall survival in patients with HER-2/neu-positive breast cancer. This is especially true when used in combination with chemotherapy and targeted therapy, such as trastuzumab (Herceptin).\n\n", "output2": "Leuprolide is a medication that can be used to improve the patient's prognosis after a modified radical mastectomy. It is a gonadotropin-releasing hormone agonist that is used to suppress the production of estrogen, which can help slow the growth of hormone receptor-positive breast cancer. In this case, the patient has been found to be positive for the HER-2/neu oncogene, which is a target for the medication.\n\n", "output3": "The patient\u2019s positive HER-2/neu oncogene status makes her a candidate for Trastuzumab therapy. Trastuzumab is a monoclonal antibody that targets the HER-2/neu protein and is used to treat breast cancer in patients with this specific genetic marker. It has been shown to improve the prognosis of HER-2/neu positive breast cancer patients.\n\n"}, {"question": "Not true about VEGF is -", "correct_answer": "Inhibits angiogenesis", "correct_idx": 2, "options": ["A)Highly specific for endothelium", "B)Hypoxia potentiates its expression", "C)Inhibits angiogenesis", "D)Helps in tumor metastasis"], "prompt": "Not true about VEGF is -A)Highly specific for endothelium\nB)Hypoxia potentiates its expression\nC)Inhibits angiogenesis\nD)Helps in tumor metastasis", "subject_name": "Pathology", "output0": "VEGF (Vascular Endothelial Growth Factor) is a protein that is highly specific for endothelial cells, which line the blood vessels. It plays a critical role in the formation of new blood vessels, and is often used as a marker of angiogenesis.\n\n", "output1": "VEGF is a protein that is produced in response to hypoxia (low oxygen levels) in the body. Hypoxia can potentiate the expression of VEGF, which in turn can stimulate angiogenesis (the formation of new blood vessels) and tumor growth.\n\n", "output2": "VEGF (Vascular Endothelial Growth Factor) is a protein that promotes angiogenesis, the formation of new blood vessels. Therefore, inhibiting its expression would prevent the formation of new blood vessels, which is the opposite of what the Turtle Technique aims to achieve.\n\n", "output3": "VEGF (Vascular Endothelial Growth Factor) is a protein that promotes the formation of new blood vessels, and it is involved in the process of tumor metastasis.\n\n"}, {"question": "Advantage of glycopyrolate over atropine is ?", "correct_answer": "It lacks CNS penetration", "correct_idx": 1, "options": ["A)It is a natural alkaloid", "B)It lacks CNS penetration", "C)Can be used in OPC poisoning", "D)Is more potent"], "prompt": "Advantage of glycopyrolate over atropine is ?A)It is a natural alkaloid\nB)It lacks CNS penetration\nC)Can be used in OPC poisoning\nD)Is more potent", "subject_name": "Pharmacology", "output0": "Glycopyrolate is a natural alkaloid that is derived from the plant Atropa belladonna. It has a similar mechanism of action to atropine, but it is considered to be more safe and effective for use in children.\n\n", "output1": "Glycopyrolate lacks central nervous system (CNS) penetration, which means it does not cross the blood-brain barrier and therefore does not have the same potential for adverse effects on the CNS as atropine.\n\n", "output2": "Glycopyrolate is more effective than atropine in treating poisoning from organophosphorus compounds (OPCs), which are a common class of pesticides. Glycopyrolate has a higher affinity for the muscarinic receptors in the body, which helps to block the effects of the toxins and reduce the severity of symptoms.\n\n", "output3": "Glycopyrolate is a synthetic alkaloid that is more potent than atropine. It has a higher affinity for muscarinic receptors and is more effective in blocking the muscarinic effects of organophosphates.\n\n"}, {"question": "What is the main function of acellular or primary cementum:", "correct_answer": "Anchorage.", "correct_idx": 2, "options": ["A)Repair.", "B)Adaptation.", "C)Anchorage.", "D)Protection."], "prompt": "What is the main function of acellular or primary cementum:A)Repair.\nB)Adaptation.\nC)Anchorage.\nD)Protection.", "subject_name": "Dental", "output0": "The main function of acellular or primary cementum is to repair the tooth-supporting tissues. It helps to fill in any gaps between the tooth and the surrounding bone, and also helps to anchor the tooth in place.\n\n", "output1": "Acellular or primary cementum is a layer of cementum that covers the root of a tooth and serves as an adaptation to the surrounding bone. It helps to anchor the tooth in place and protect it from decay and damage.\n\n", "output2": "The main function of acellular or primary cementum is to provide anchorage for the teeth in the jawbone. It helps to secure the teeth in their sockets and prevent them from shifting or falling out.\n\n", "output3": "The main function of acellular or primary cementum is to provide protection to the tooth root. It also serves as an attachment point for periodontal ligament fibers and helps to anchor the tooth in place.\n\n"}, {"question": "As per the bone bending theory, the convex surface:", "correct_answer": "Acquires positive charge", "correct_idx": 1, "options": ["A)Acquires negative charge", "B)Acquires positive charge", "C)May acquire positive or negative charge", "D)Does not show any charge on surface"], "prompt": "As per the bone bending theory, the convex surface:A)Acquires negative charge\nB)Acquires positive charge\nC)May acquire positive or negative charge\nD)Does not show any charge on surface", "subject_name": "Dental", "output0": "According to the bone bending theory, the convex surface of a bone acquires a negative charge due to the compression of the bone tissue. This charge is believed to play a role in the regulation of the bone's mechanical properties.\n\n", "output1": "According to the bone bending theory, the convex surface of the turtle's shell acquires a positive charge. This is because the surface of the shell is made up of bony plates that are covered with a layer of keratin, a protein that is negatively charged. When the turtle withdraws its head and limbs into its shell, the positive charge on the convex surface of the shell helps to attract the negative charge on the keratin, creating a strong bond between the two.\n\n", "output2": "According to the bone bending theory, the convex surface of a bone may acquire a positive or negative charge depending on the type of bone and the position of the bone in the body. This charge is believed to play a role in the regulation of muscle contractions and the maintenance of posture and movement.\n\n", "output3": "According to the bone bending theory, the convex surface of the turtle shell does not show any charge on its surface. This is because the turtle shell is made of bone, which is an insulator and does not conduct electricity.\n\n"}]